TalleyNJZinsmeisterARSchleckCDMeltonLJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology1992; 101:1259–68.
2.
JonesRLydeardS. Dyspepsia in the community: a follow up study. Br J Clin Pract1992; 46:95–7.
3.
JohannessenTPetersenHKlevellPM. The predictive value of history in dyspepsia. Scand J Gastroenterolol1990; 25:689–97.
4.
TalleyNJJonesDKochK. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int1991; 4:145–60.
5.
BarbaraLCamilleriMCorinaldesiR. Definition and investigation of dyspepsia: consensus of an international ad hoc working party. Dig Dis Sci1989; 34:1272–6.
6.
ForbatLNGribbleRJBaronJH. Gastrointestinal endoscopy in the young. BMJ1987; 295:365.
7.
LockhartSPScholfieldPMGribbleRJBaronJH. Upper gastrointestinal endoscopy in the elderly. BMJ1985; 290:283.
8.
RicherJE. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol Suppl1991; 182:11–6.
9.
KangJYYapIGweeKA. The pattern of functional and organic disorders in an Asian gastroenterological clinic. J Gastroenterol Hepatol1994; 9:124–7.
10.
LockeGRTalleyNJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol1993; 8:279–86.
11.
TalleyNJ. Modern management of dyspepsia. Aust Fam Physician1996; 25:47–52.
12.
FisherRSParkmanHP. Management of nonulcer dyspepsia. N Eng JMed1998; 339:1376–81.
13.
ChristieJShepherdNACodlingBWValoriRM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut1997; 41:513–7.
14.
AxonATR. Chronic dyspepsia: who needs endoscopy?Gastroenterology1997; 112:1376–80.
15.
LydeardSJonesR. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract1989; 39:495–8.
16.
McQuaidK. Dyspepsia. In: FeldmanMScharschmidtBFSleisengerMH eds. Sleisenger and Fordtran's gastrointestinal and liver diseasePhiladelphia: WB Saunders Company, 1998; 1:105–15.
17.
NyrenO. Therapeutic trial in dyspepsia: its role in the primary care setting. Scand J Gastroenterol1991; 182(suppl.):61–9.
18.
CamilleriM. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc1996; 71:614–22.
19.
ThompsonWG. Dyspspsia: is a trial of therapy appropriate?Can Med Assoc J1995; 153:293–9.
20.
BytzerPHansenJMSchaffalitzky de MuckadellOB. Empirical H2 blocker therapy or prompt endoscopy in management of dyspepsia. Lancet1994; 343:811–6.
21.
BytzerP. Diagnosing dyspepsia: any controversies left?Gastroenterology1996; 110:302–6.
22.
TalleyNJWeaverALTesmerKLZinsmeisterAR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology1993; 105:1378.
23.
SmallPKLoudonMAWaldronB. Importance of reflux symptoms in functional dyspepsia. Gut1995; 36:189.
24.
SielaffF. Coincidence between chronic dyspepsia and irritable bowel syndrome. Eur J Gastroenterol Hep1990; 2:S105–6.
25.
TalleyNJ. Spectrum of chronic dyspepsia in the presence of the irritable bowel syndrome. Scand J Gastroenterol1991; 26:7–10.
26.
ThompsonWGDotevallGDrossmanDA. Irritable bowel syndrome: guidelines for diagnosis. Gastroenterol Int1989; 2:92–5.
27.
HoKYKangJYSeowA. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gasteroenterol1998; 93:1816–22.
28.
CreanGPHoldenRJKnill-JonesRP. A database on dyspepsia. Gut1994; 35:191–202.
29.
RichterJE. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol1991; 26:11–6.
30.
JohnsenRBernersenBStraumeB. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ1991; 302:749–52.
31.
TalleyNJPhillipsSF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med1988; 108:865–79.
32.
WaldronBCullenPTKumarR. Evidence for hypomotility in non ulcer dyspepsia: a prospective multifactorial study. Gut1991; 32:246–51.
33.
Di LorenzoCHymanPEFloresAF. Antroduodenal manometry in children and adults with severe non-ulcer dyspepsia. Scand J Gastroenterol1994; 29:799–806.
34.
MittalBRDhimanRKMainiA. Gastric emptying in patients with non-ulcer dyspepsia (dysmotility type). Trop Gastroenterol1997; 18:67–9.
LemannMDederdingJPFlourieB. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia: the irritable stomach syndrome. Dig Dis Sci1991; 36:1249–54.
37.
CoffinBAzpiroz, GuarnerFMalageladaJR. Selective gastric hypersensitivity and reflux hypoactivity in functional dyspepsia. Gastroenterology1994; 107:1345–51.
38.
RichterJE. Stress and psychological and environmental factors in functiScand J Gastroenterol1991; 182(suppl.):40–6.
39.
HaugTTSvebakSWilhelmsenI. Psychological factors and somatic symptoms in functional dyspepsia: a comparison with duodenal ulcer and healthy controls. J Psychosom Res1994; 38:281–91.
40.
JainAKGuptaJPGuptaS. Neuroticism and stress life events in patients with non-ulcer dyspepsia. J Assoc Physicians India1995; 43:90–1.
41.
HaugTTSvebakSWilhelmsenI. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med1994; 56:181–6.
42.
TalleyNJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol1996; 220(suppl.):19–22.
43.
O'MorainCGilvarryJ. Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Scand J Gastroenterol1993; 196(suppl.):30–3.
44.
Veldhuysen van ZantenSJOShermanPM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. Can Med Assoc1994; 150:177–85.
45.
NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA1994; 272:65–9.
46.
EltaGHScheimanJMBarnettJL. Long term follow up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Am J Gastroenterol1995; 90:1089–93.
47.
KangJYFockKMNgHS. Working party report of the Gastroenterological Society of Singapore. Part II - Helicobacter pylori and non-ulcer dyspepsia in Singapore. Sing Med J1996; 37:428–9.
48.
HoltmannGTalleyNJ. Functional dyspepsia. Current treatment recommendations. Drugs1993; 45:918–30.
49.
JohnsonAG. Controlled trial of metaclopramide in the treatment of flatulent dyspepsia. BMJ1971; 2:25–6.
50.
DobrillaGComberlatoMSteeleAVallapertaP. Drug treatment of functional dyspepsia: a meta-analysis of randomised controlled clinical trials. J Clin Gastroenterol1989; 11:169–77.
51.
TalleyNJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol Suppl1991; 182:47–60.
52.
KellowJECowanHShuterB. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther1995; 9:153–60.
53.
JianRDucrotFRuskoneA. Symptomatic radionuclide and therapeutic assessment of chronic idiopathic dyspepsia: a placebo-controlled evaluation of cisapride. Dig Dis Sci1989; 34:657–64.
54.
YeohKGKangJYTayHH. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. J Gastroenterol Hepatol1997; 12:13–8.
55.
TalleyNJ. Functional dyspepsia - should treatment be targeted on disturbed physiology?Aliment Pharmacol Ther1995; 9:107–15.
56.
Veldhuyzen van ZantenSJOClearyC. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol1996; 91:660–73.
57.
Food and Drug Administration. FDA strengthens warning label for Propulsid. Media release. 29 June 1998.
58.
GotthardRBodemarGBrodinUJonssonKA. Treatment with cimetidine, antacid or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol1988; 23:7–18.
59.
NyrenOAdamiHOBatesS. Absence of therapeutic benefit from antacids or cimetidine in non ulcer dyspepsia. N Engl J Med1986; 314:339–43.
60.
CarlssonRBollingEJerndalP. Factors predicting response to omeprazole treatment in patients with functional dyspepsia. Gastroenterology1996; 110:A76.
61.
Meineche-SchmidtVKragEChristensenE. Identification of omeprazole response in dyspepsia. Data analysis of a Danish multicentre trial in general practice. Gastroenterology1995; 108:A165.
62.
ClouseRE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci1994; 39:2352–63.
63.
HradskyMWikanderM. Effect of pirenzepine in the treatment of non-ulcer dyspepsia. A double-blind study. Scand J Gastroenterol1982; 17:251–4.
64.
HauskenTStene-LarsenGLangeO. Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and eroside prepyloric changes. A double blind, placebo-controlled multicentre study. Scand J Gastroenterol1990; 25:1028–33.
65.
Skoubo-KristensenEFunch-JensenPKruseA. Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis. ScandJ Gastroenterol1989; 24:716–20.
66.
GudjonssonHOddssonEBjornssonS. Efficacy in treatment of non-ulcer dyspepsia. A double-blind placebo controlled study. Scand J Gastroenterol1993; 28:969–72.
67.
FraitagB. Homerin M, Hecketsweiler P. Double-blind dose response multicentre comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci1994; 39:1072–7.
68.
TalleyNJWeaverALZinmeisterARMeltonLJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol1992; 136:165–77.
69.
TalleyNJMcNeilDHaydenA. Prognosis of chronic unexplained dyspepsia: a prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology1987; 92:1060–6.
70.
SircusW. Duodenitis: a clinical, endoscopic and histopathologic study. QJM1985; 56:593–600.
71.
TytgatGNJNoachLARauwsEAJ. Is gastroduodenitis a cause of chronic dyspepsia?Scand J Gastroenterol Suppl 1991; 182:33–9.